Alliance for Human Research Protection Fri, 18 Jul 2003 Dear Dr. Campbell and others concerned about ethical research: This is in response to your July 11 comments objecting to AHRP’s criticism of the ethics of two controversial ARDS experiments sponsored by the . . . Continue reading →
John H. Noble
Antidepressants shown worthless for most consumers
The comments below expand upon an Infomail about the recently published JAMA meta-analysis.
AHRP in the News
Alliance for Human Research Protection in the Press Feb 17, 2005: FDA Critics Slam Plan for Safety Reform – Nature “This is smoke and mirrors and musical chairs,” says Vera Sharav, president of the New York-based Alliance for Human Research Protection. “They . . . Continue reading →
Article
From: “VERACARE” To: “Dr. Bart Campbell” Subject: RE: AHRP Response to criticism re: fatal ARDS lung experiment Date: Tue, 1 Jul 2003 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org//testimonypresentations/ARDSNet0603/sharav.html
Children are Humans: Don’t Sacrifice their Rights, Dignity & Welfare
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 Fax: 212-595-9086 142 West End Ave. Suite 28P New York, NY 10023 Co-founders: Vera Hassner Sharav, President John H. Noble, Jr., PhD, Treasurer David Cohen, Ph.D., Secretary March 27, 2003 March 27, 2003 Senate . . . Continue reading →
FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP
FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and . . . Continue reading →
Dissenting Opinion: Against waiving parental permission for research
Dissenting Opinion: Against Waiving Parental Permission for Research July 25, 2001 To: Mary Faith Marshall, Ph.D, Chairperson, National Human Research Protections Advisory Committee Department of Health and Human Services Re: Specific Comment on FDA’s Decision to Adopt HHS 45 CFR 46 Subpart . . . Continue reading →
Research Protection for Children
AHRP Campaign to Protect Children from Harm Oct 15: FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical Deception Sep 30: GSK . . . Continue reading →
ARDSNet – AHRP Reply to OHRP Response
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave, Suite 28P New York, NY 10023 212-595-8974 ahrp@researchprotection.org September 4, 2002 Michael Carome, MD Associate Director for Regulatory Affairs Office for Human Research Protections The Tower Building 1101 Wootton Parkway, Suite . . . Continue reading →
OHRP Response to AHRP re: Surrogate Consent to Research
OHRP Response to AHRP re: Surrogate Consent to Research Office of the Secretary Department of Health & Human Services Office of Public Health and Science Office for Human Research Protections Rockville, Maryland E-mail: mcarome@osophs.dhhs.gov August 28, 2002 Vera Hassner Sharav President, The . . . Continue reading →
Protecting People w Mental Disabilities & Impairments against Biomedical Research Abuse
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and . . . Continue reading →
Protecting Human Subjects in Research: Are Current Safeguards Adequate?
Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on . . . Continue reading →